Strategic services for the departments Finance, IT, QM and Regulatory Affairs within the PARI Group

Development, sales and marketing of PARI products as well as other products for respiratory tract treatment and diagnostics worldwide (except North America).

Innovative aerosol treatment for pulmonary and nasal applications based on optimised drug and device systems (eFlow® technology).

Production and logistics for medical engineering with a focus on inhalation devices and efficient nebuliser systems.